Does Coronavirus Disease 2019 Disprove the Obesity Paradox in Acute Respiratory Distress Syndrome?
作者信息
Jose Ricardo J, Manuel Ari
机构信息
Department of Respiratory Medicine (Host Defence), Royal Brompton Hospital, Chelsea, UK.
Centre for Inflammation and Tissue Repair, Research Department of Respiratory Medicine, University College of London, London, UK.
出版信息
Obesity (Silver Spring). 2020 Jun;28(6):1007. doi: 10.1002/oby.22835.
Abstract
摘要
相似文献
1
Does Coronavirus Disease 2019 Disprove the Obesity Paradox in Acute Respiratory Distress Syndrome?2019冠状病毒病是否反驳了急性呼吸窘迫综合征中的肥胖悖论？
Obesity (Silver Spring). 2020 Jun;28(6):1007. doi: 10.1002/oby.22835.
2
Extracorporeal membrane oxygenation for acute respiratory distress syndrome in patients with coronavirus disease 2019: what do we know so far?2019冠状病毒病患者急性呼吸窘迫综合征的体外膜肺氧合：我们目前了解多少？
Perfusion. 2020 Sep;35(6):558-561. doi: 10.1177/0267659120934279. Epub 2020 Jun 24.
3
Acute respiratory distress syndrome and steroids in the shadow of coronavirus disease 2019.2019冠状病毒病阴影下的急性呼吸窘迫综合征与类固醇
Pol Arch Intern Med. 2020 Apr 30;130(4):266-267. doi: 10.20452/pamw.15325.
4
Heterogeneity of Acute Respiratory Distress Syndrome in COVID-19: "Typical" or Not?新型冠状病毒肺炎中急性呼吸窘迫综合征的异质性：是否为“典型”？
Am J Respir Crit Care Med. 2020 Aug 15;202(4):618-619. doi: 10.1164/rccm.202004-1106LE.
5
Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19.在部分与新型冠状病毒肺炎相关的严重急性呼吸窘迫综合征患者中使用皮质类固醇。
J Infect. 2020 Aug;81(2):e89-e90. doi: 10.1016/j.jinf.2020.05.023. Epub 2020 May 14.
6
Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?新型冠状病毒肺炎中的肺力学类似呼吸窘迫综合征，而非急性呼吸窘迫综合征：表面活性剂能否成为一种治疗方法？
Am J Respir Crit Care Med. 2020 Aug 15;202(4):624-626. doi: 10.1164/rccm.202004-1471LE.
7
Ethics and extracorporeal membrane oxygenation during coronavirus disease 2019 outbreak.2019冠状病毒病疫情期间的伦理与体外膜肺氧合
Perfusion. 2020 Sep;35(6):562-564. doi: 10.1177/0267659120937545. Epub 2020 Jun 25.
8
COVID-19 Lung Injury and "Typical" Acute Respiratory Distress Syndrome: The Danger of Presumed Equivalency.新型冠状病毒肺炎所致肺损伤与“典型”急性呼吸窘迫综合征：假定等同性的风险
Ann Am Thorac Soc. 2020 Sep;17(9):1171-1172. doi: 10.1513/AnnalsATS.202005-405LE.
9
Treatment for severe acute respiratory distress syndrome from COVID-19.新型冠状病毒肺炎所致严重急性呼吸窘迫综合征的治疗
Lancet Respir Med. 2020 May;8(5):433-434. doi: 10.1016/S2213-2600(20)30127-2. Epub 2020 Mar 20.
10
Covid-19, Angiogenesis, and ARDS Endotypes.新型冠状病毒肺炎、血管生成与急性呼吸窘迫综合征的内型
N Engl J Med. 2020 Jul 9;383(2):182-183. doi: 10.1056/NEJMe2018629. Epub 2020 May 21.
引用本文的文献
1
Casual correlation between overweight, obesity, and severe COVID-19 infection with respiratory failure: A two-sample Mendelian randomization.超重、肥胖与伴有呼吸衰竭的重症新型冠状病毒肺炎感染之间的偶然关联：一项两样本孟德尔随机化研究
Medicine (Baltimore). 2025 Jan 3;104(1):e41006. doi: 10.1097/MD.0000000000041006.
2
Gestational weight gain during pregnancy is the risk factor for Omicron infection: a retrospective case-control study.孕期体重增加是感染奥密克戎的危险因素：一项回顾性病例对照研究。
BMC Pregnancy Childbirth. 2024 Dec 18;24(1):818. doi: 10.1186/s12884-024-07025-6.
3
Interplay between Comorbidities and Long COVID: Challenges and Multidisciplinary Approaches.共病与长新冠之间的相互作用：挑战和多学科方法。
Biomolecules. 2024 Jul 11;14(7):835. doi: 10.3390/biom14070835.
4
SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines.严重急性呼吸综合征冠状病毒2：发病机制、治疗方法、变体和疫苗。
Front Microbiol. 2024 Jun 13;15:1334152. doi: 10.3389/fmicb.2024.1334152. eCollection 2024.
5
Higher body mass index is strongly linked to poor outcomes in adult COVID-19 hospitalizations: A National Inpatient Sample Study.较高的体重指数与成人新冠病毒肺炎住院患者的不良预后密切相关：一项全国住院患者样本研究。
Obes Sci Pract. 2023 Sep 11;10(1):e692. doi: 10.1002/osp4.692. eCollection 2024 Feb.
6
Body Mass Index as a Major Prognostic Contributing Factor in COVID-19: A Multicentral Egyptian Study.体重指数作为COVID-19主要预后影响因素：一项埃及多中心研究。
Infect Drug Resist. 2023 Sep 8;16:5985-6004. doi: 10.2147/IDR.S426440. eCollection 2023.
7
Impact of Covid-19 lockdown on sleep quality, physical activity, and body weight among university students: A retrospective cross-sectional study.新冠疫情封锁对大学生睡眠质量、身体活动和体重的影响：一项回顾性横断面研究。
J Educ Health Promot. 2023 Mar 31;12:79. doi: 10.4103/jehp.jehp_1381_21. eCollection 2023.
8
Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance.新冠病毒相关急性呼吸窘迫综合征的细胞和分子特征：治疗意义
J Inflamm (Lond). 2023 Mar 20;20(1):11. doi: 10.1186/s12950-023-00333-2.
9
The impact of obesity on the outcome of severe SARS-CoV-2 ARDS in a high volume ECMO centre: ECMO and corticosteroids support the obesity paradox.肥胖对大容量 ECMO 中心严重 SARS-CoV-2 ARDS 结局的影响：ECMO 和皮质类固醇支持肥胖悖论。
J Crit Care. 2022 Dec;72:154162. doi: 10.1016/j.jcrc.2022.154162. Epub 2022 Oct 8.
10
A Review of COVID-19 in Relation to Metabolic Syndrome: Obesity, Hypertension, Diabetes, and Dyslipidemia.与代谢综合征相关的2019冠状病毒病综述：肥胖、高血压、糖尿病和血脂异常
Cureus. 2022 Jul 29;14(7):e27438. doi: 10.7759/cureus.27438. eCollection 2022 Jul.
本文引用的文献
1
COVID 19 and the Patient with Obesity - The Editors Speak Out.2019冠状病毒病与肥胖患者——编辑发声
Obesity (Silver Spring). 2020 May;28(5):847. doi: 10.1002/oby.22808. Epub 2020 Apr 1.
2
Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19).早期抗病毒治疗有助于减轻新型冠状病毒病 (COVID-19) 患者的病情严重程度并改善预后。
J Intern Med. 2020 Jul;288(1):128-138. doi: 10.1111/joim.13063. Epub 2020 Apr 20.
3
[Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV].112例2019新型冠状病毒感染心血管疾病患者的临床特征与结局
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jun 24;48(6):450-455. doi: 10.3760/cma.j.cn112148-20200220-00105.
4
Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis.体质量指数能否预测急性肺损伤/急性呼吸窘迫综合征患者的临床结局？一项荟萃分析。
Crit Care. 2017 Feb 22;21(1):36. doi: 10.1186/s13054-017-1615-3.
5
Perioperative management of obese patients.肥胖患者的围手术期管理。
Best Pract Res Clin Anaesthesiol. 2010 Jun;24(2):211-25. doi: 10.1016/j.bpa.2010.02.001.
Zotero 插件